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Abstract 
Osteopetrosis is a rare genetic disorder characterized by 
functional defect of osteoclasts resulting in failure of bone 
resorption, increased bone sclerosis and bone marrow 
failure. Patients present with stunted growth, skeletal 
changes, hepatosplenomegaly, features of pancytopenia 
and characteristic radiological changes. Osteopetrosis has 
variable inheritance pattern. Diagnosis is made on the 
basis of history with clinical findings, characteristic 
radiological and bone marrow findings. We present a case 
of a 10 years old female child with stunted growth, frontal 
bossing, teeth abnormalities and characteristic radiological 
and bone marrow findings. 
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Introduction 
Osteopetrosis (OP) refers to a group of rare genetic disorder 
characterized by increased bone density on radiographs. The 
condition varies in presentation and severity ranging from 
neonatal onset with life threatening complications such as 
bone marrow failure to an incidental finding. The term 
Osteopetrosis is derived from Greek, osteo meaning bone 
and petros meaning stone. OP is also known as marble bone 
disease and Albers-Scharberg disease, after the name of 
German radiologist who gave first description of disease.1  
The primary underlying defect in all types of osteopetrosis is 
failure of the osteoclasts to reabsorb bone resulting in 
thickened sclerotic bones, which have poor mechanical 
properties. Increased bone fragility results from a failure of 
the collagen fibers to connect osteons properly and from 
defective remodelling of woven bone to compact bone. 2 
This leads to generalized sclerosis of bone with an increased 
skeletal mass due to abnormally dense bone. Mutations in at 
least 10 genes have been identified. Generalized 
osteosclerosis is apparent radiographically, often with a 
“bone within a bone” appearance.3 In severely affected 
patients, the medullary cavity is filled with endochondral 
new bone, with little space remaining for hematopoietic 
cells. This abnormality contributes to the brittleness of bone 
in osteopetrosis. The abnormal skeletal radiographs and 
microscopic appearance of bone can be reversed by 
hematopoietic stem-cell transplantation.4 Overall, the 
incidence of the disease is estimated at 1 in 100,000-
500,000. However, the actual incidence is unknown because 
no large epidemiological studies have been conducted so 
far.5  
The condition may be inherited as Autosomal recessive, 
autosomal dominant or X- linked trait. Autosomal OP also 
known as malignant OP is the most severe of all genetic 
variants and manifests classically in first few months of life. 
Characteristic features include short stature, macrocephaly, 
frontal bossing, tooth eruption defects and dental caries. 
Increased bone density can produce weakness of bones 
resulting in predisposition to fractures and osteomyelitis. 
The expanding bone can narrow nerve foramens resulting in 
signs of nerve compression such as blindness, deafness and 
facial palsy.  These children are also at a risk of developing 
hypocalcaemia which may result in tetanic seizures and 
secondary hyper parathyroidism. Hematological findings are 
due to obliteration of bone marrow cavity by bone, causing 
myelophthisic anemia, which manifests as a 
leukoerythroblastic picture on peripheral blood smear. The 
most severe complication of OP is bone marrow suppression 
resulting in life threatening pancytopenia. 
Hepatosplenomegaly is due to extra medullary 
hematopoiesis. Thrombocytopenia, leukopenia and anemia 
may also occur due to hypersplenism. Many patients of 
malignant recessive osteopetrosis become transfusion 
dependant. 6  
Variants of AROP may have neurological and renal 
manifestations. Autosomal dominant OP typically have 
onset in late childhood and adolescence. Patients classically 
have the radiographic signs of sandwich vertebrae, fractures, 
scoliosis, osteoarthritis and osteomyelitis particularly 
affecting mandible in association with dental caries and 
abscesses. X linked OP is rare and is characterized by 
immunodeficiency with ectodermal changes.   
The diagnosis of OP depends upon clinical, radiographic 
and bone marrow findings. The classic radiological features 
of osteopetrosis include diffuse sclerosis, affecting the skull, 
spine, pelvis and appendicular bones, bone modelling 
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defects, "Bone-in-bone" appearance particularly in the 
vertebrae and phalanges and focal sclerosis of the skull base, 
pelvis and vertebral end plates giving "sandwich" 
appearance. Bone marrow typically shows increased bone 
density with reduction or absence of medullary cavity and 
markedly decreased hematopoietic tissue. Once the 
diagnosis of a primary osteopetrosis is made, it is important 
to distinguish between different subtypes as they have 
different responses to treatment, prognosis and recurrence 
risks. 
We present a case of a 10 years old female child who 
presented with anemia and thrombocytopenia and on 
radiological evaluation and bone marrow examination was 
diagnosed as a case of Osteopetrosis. 
 
                
 
 
                    
 
Figure 1: Patient of Osteopetrosis showing: 
 
a. frontal bossing; b. Dental abnormalities 
Case Report 
A ten years old female child presented in OPD at social 
security hospital Islamabad, with history of generalized 
bodyache and pain in legs for the past 4-5 years. She was 
the product of consanguineous marriage. There was no 
history of transfusion in the past. She was a short statured 
child and also had frontal bossing. On examination of oral 
cavity, dental caries was observed in many teeth. She was 
mildly pale. There was no lymphadenopathy or 
hepatosplenomegaly. Her blood complete picture showed 
Hb 8.4 gms/dl, TLC 8.4 x 106/l; platelet count 110 x 109/l, 
MCV 77.3 fl, MCH 23.1 pg and MCHC 29.9 g/dl. Her 
biochemical profile showed serum Calcium: 8.6 mg/dl, PO4: 
4.7 mg/dl and Alkaline Phosphatase: 559 IU/l. She was sent 
for radiological evaluation. X-rays of spine, skull, long bone 
and hands were taken. Radiological evaluation showed 
increased bone density with increased thickening of bony 
cortices with diagnosis of osteopetrosis. She was referred to 
us for bone marrow biopsy. Bony texture was stony hard. 
Bone marrow aspirate was hypocellular with hypoplastic 
erythroid, myeloid and megakaryocytic series cells. No 
abnormal cells were found. Histological section of trephine 
biopsy showed hypocellular bone marrow fragments with 
decrease in erythroid, myeloid and megakaryocytic series 
cells. Bone marrow fragments were replaced by new bone 
formation (at different stages of ossification). Final 
diagnosis was osteopetrosis. 
 
 
 
 
 
 
 
 
 
 
Figure 2:  Sclerotic bones 
a. Skull 
b. Ulna & radius 
c. Wrist and  
hand 
 
 
                                                      
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Trephine biopsy shows widening of bone trabeculae, and 
evidence of bone formation in the bone marrow fragments. Bone has 
encroached into the bone marrow replacing normal marrow cells 
Discussion 
Osteopetrosis, also called marble bone disease, was first 
described by Heinrich Albers-Schonberg in 1904 which is a 
heterogeneous group of heritable conditions in which there 
is a defect in bone resorption by osteoclasts. Hallmark of 
disease is increased bone density on radiographs resulting 
from failure of osteoclast development or function, 
decreased bone resorption and thickened sclerotic bone. 
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Osteopetrosis varies in severity depending on mode of 
inheritance and time of presentation.  Based on the age, 
clinical, hematological and radiological features three 
distinct forms namely the infantile or AR, adult (AD) form, 
and intermediate OP.7 The AR variety is also known as 
congenital or infantile or malignant OP occurs in infancy 
and has a rapid downhill course due to severe bone marrow 
failure.8  Features of infantile osteopetrosis  include dense 
and deformed bones, growth failure, anemia,  
hypoplastic dentition, chronic infection, splenomegaly and 
neurological impairment. 
Adult type of OP has an autosomal dominant inheritance 
pattern and approximately one half of the patients are 
asymptomatic, and the diagnosis is made incidentally or is 
based on family history. Autosomal recessive osteopetrosis 
may have less severe manifestations and is known as 
“intermediate” autosomal recessive osteopetrosis (in which 
bony changes are there but bone marrow failure is not 
prominent and it has poor prognosis).9 Recently a case has 
been described with abnormal bone modelling, increased 
bone density and histological features of osteopetrosis in a 
12-year-old boy with extended bisphosphonate therapy. This 
case suggests that agents that inhibit the recruitment and 
function of osteoclasts, when given over an extended period 
of time, may cause a clinical picture comparable to heritable 
osteopetrosis and has been designated as acquired 
osteopetrosis.10 
We present a case of autosomal recessive osteopetrosis 
which is probably of intermediate severity as she is 10 years 
old girl and has presented with bony changes and anemia 
but there is no history of transfusion in past. Her trephine 
showed sclerotic changes but there was still some residual 
marrow seen on bone marrow trephine. Her two siblings 
however died at the age of 3 and 3.5 years with same 
disease probably having severe form of malignant 
osteopetrosis. Osteopetrosis is a rare cause of anemia both in 
infantile and adult varieties, 11 due to replacement of 
hemopoietic tissue by bone marrow sclerosis. In a study 
done in India on clinical and laboratory features of 6 
patients of infantile osteopetrosis in 5 years duration, 
increasing pallor and listlessness were the most common 
initial symptom. Other features included abdominal 
distension, fever, frontal bossing, nasal block, anemia and 
thrombocytopenia. 12 The risk of developing hematological 
impairment in the first year of life is about 75% and its onset 
within 3 months of life is indicative of a poor outcome.13  
Infantile osteopetrosis requires treatment due to the adverse 
outcome associated with the disease. Calcitriol may help by 
stimulating dormant osteoclasts and, thus, stimulating bone 
resorption. However it only produces a modest clinical 
improvement, which is not sustained after discontinuation of 
therapy.14 Erythropoietin can be used to correct anemia. 
Children with infantile osteopetrosis have disease-related 
complications that affect nutritional status. Good nutritional 
support can provide nutrients needed for improved growth 
and response to treatment in these patients. Recently, use of 
interferon gamma has been found to decrease the rate of 
infection and transfusion requirements after 24 months of 
therapy. The natural course of the disease results in survival 
of about 30% of patients at six years of age. Some may live 
till 2nd or 3rd decade but the quality of life is mostly poor. 
Bone marrow transplant is the only treatment that can be 
offered to cure the disease and has remarkably shown 
improvement in some cases of osteopetrosis. Recipients of 
HLA identical BMT have been reported to have 5 year 
survival of 79%.15   It can cure both bone marrow failure 
and metabolic abnormalities. However in adult OP which 
has relatively normal bone marrow function no specific 
medical treatment exists.  
Though rare, AR osteopetrosis should be considered in the 
differential diagnosis of an infant or young child presenting 
with anemia with or without hepatosplenomegaly. An 
accurate diagnosis is essential in view of 
availability of curative treatment and for genetic counseling.  
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